Published in Antimicrob Agents Chemother on December 01, 1996
Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev (2002) 2.43
Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Antimicrob Agents Chemother (1999) 2.02
In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob Agents Chemother (1997) 1.76
Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother (1999) 1.70
The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen. Infect Immun (1998) 1.46
In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone. Antimicrob Agents Chemother (2003) 1.30
Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother (2003) 1.16
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin? J Bacteriol (1999) 1.06
Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases. Eur J Clin Microbiol Infect Dis (1998) 0.98
Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins. Infect Immun (2000) 0.98
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. Antimicrob Agents Chemother (2003) 0.96
Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates. J Clin Microbiol (2002) 0.90
Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model. Infect Immun (2007) 0.89
Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. Antimicrob Agents Chemother (2000) 0.88
Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections. Infect Drug Resist (2015) 0.75
Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother (1990) 4.14
In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993. Antimicrob Agents Chemother (1994) 3.59
Branhamella catarrhalis--an emerging human pathogen. Diagn Microbiol Infect Dis (1986) 1.86
beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrob Agents Chemother (1982) 1.65
In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods. Antimicrob Agents Chemother (1988) 1.55
Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States. Drugs (1986) 1.26
Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis. Drugs (1986) 1.20
Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis. Antimicrob Agents Chemother (1989) 1.16
Spectrum of disease due to Branhamella catarrhalis in children with particular reference to acute otitis media. Am J Med (1990) 1.10
Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts. Am J Med (1990) 1.02
Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother (1996) 5.68
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol (2002) 3.30
Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995. Antimicrob Agents Chemother (2001) 3.23
Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother (1997) 2.91
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98. Emerg Infect Dis (2000) 2.63
Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop Med Hyg (1979) 2.51
Situs revisited: imaging of the heterotaxy syndrome. Radiographics (1999) 2.33
Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother (1996) 2.22
Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. Clin Infect Dis (1999) 2.16
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet (2008) 2.09
Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Antimicrob Agents Chemother (1999) 2.02
Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States. Clin Infect Dis (1998) 1.96
Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood (1990) 1.93
The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Clin Infect Dis (2001) 1.91
Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines. Infect Immun (1980) 1.77
Impact of legislation raising the legal drinking age in Massachusetts from 18 to 20. Am J Public Health (1983) 1.76
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet (2009) 1.74
Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol (1997) 1.64
High rates of depressive symptoms in STD clinic patients. Sex Transm Dis (2001) 1.64
Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2. J Med Genet (2005) 1.62
Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis (1993) 1.54
Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain. Infect Immun (1979) 1.51
Simultaneous respiratory tract colonization by multiple strains of nontypeable haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy. J Infect Dis (1999) 1.49
Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax (2001) 1.47
A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions. Int J Antimicrob Agents (1999) 1.43
Cryptosporidium: a common cause of parasitic diarrhea in otherwise healthy individuals. J Infect Dis (1986) 1.42
Elastin: mutational spectrum in supravalvular aortic stenosis. Eur J Hum Genet (2000) 1.40
Syndromal foramina parietalia permagna: "new" or FG syndrome? Comments on the paper by Chrzanowska et al [1998]. Am J Med Genet (1998) 1.40
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39
Temperature-sensitive mutants of influenza A virus: evaluation of the Alaska/77-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers. Arch Virol (1980) 1.39
Concentration of thyroxine-binding globulin: value of direct assay. Br Med J (1977) 1.37
Immunogenic effect of inactivated hepatitis B vaccine: comparison of 20 microgram and 40 microgram doses. J Med Virol (1981) 1.36
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun (1992) 1.33
Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus. J Gen Microbiol (1993) 1.33
Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers. Infect Immun (1978) 1.30
Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States: a report from the College of American Pathologists Microbiology Proficiency Survey Program. Arch Pathol Lab Med (1999) 1.30
Induction, binding specificity and function of human ICOS. Eur J Immunol (2000) 1.30
Four-day incubation period for blood culture bottles processed with the Difco ESP blood culture system. J Clin Microbiol (1997) 1.27
Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally. Infect Immun (1978) 1.22
A novel 22q11.2 microdeletion in DiGeorge syndrome. Am J Hum Genet (1999) 1.20
A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin. J Perinatol (2006) 1.20
Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae. Emerg Infect Dis (2000) 1.17
False-negative results using Neisseria gonorrhoeae porA pseudogene PCR - a clinical gonococcal isolate with an N. meningitidis porA sequence, Australia, March 2011. Euro Surveill (2011) 1.13
In-Frame Deletion and Missense Mutations of the C-Terminal Helicase Domain of SMARCA2 in Three Patients with Nicolaides-Baraitser Syndrome. Mol Syndromol (2012) 1.11
Snoring in French preschool children. Pediatr Pulmonol (1992) 1.11
A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol (2000) 1.10
Partial deletion of the critical 1.5 Mb interval in Williams-Beuren syndrome. J Med Genet (2003) 1.10
Further delineation of Pitt-Hopkins syndrome: phenotypic and genotypic description of 16 novel patients. J Med Genet (2008) 1.10
Neocentric small supernumerary marker chromosomes (sSMC)--three more cases and review of the literature. Cytogenet Genome Res (2007) 1.09
Staphylococcus aureus Cowan I-induced immunoglobulin production in human cord blood lymphocytes. J Immunol (1980) 1.08
Persistent bacteremia in staphylococcal endocarditis. Am J Med (1978) 1.07
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis (1998) 1.07
The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera. Trans R Soc Trop Med Hyg (1979) 1.06
Co-elimination of mec and spa genes in Staphylococcus aureus and the effect of agr and protein A production on bacterial adherence to cell monolayers. J Med Microbiol (1993) 1.06
Factors affecting interictal spike discharges in adults with epilepsy. Electroencephalogr Clin Neurophysiol (1990) 1.03
Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (DGS2). Eur J Hum Genet (1998) 1.00
Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J (2011) 1.00
Current controversies in the detection of septicemia. Eur J Clin Microbiol (1986) 0.99
Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. Virology (2000) 0.99
Computer applications for staff development and patient education. Methods Inf Med (1989) 0.98
Fun and games in nursing staff development. J Contin Educ Nurs (1992) 0.96
Genitourinary anomalies in Mowat-Wilson syndrome with deletion/mutation in the zinc finger homeo box 1B gene (ZFHX1B). Report of three Italian cases with hypospadias and review. Horm Res (2005) 0.96
Assessment of the oxacillin disk screening test for determining penicillin resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis (1997) 0.94
Characterisation of deletions of the ZFHX1B region and genotype-phenotype analysis in Mowat-Wilson syndrome. J Med Genet (2003) 0.94
Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients. J Med Genet (2004) 0.94
Dexamethasone down-regulates the expression of L-selectin on the surface of neutrophils and lymphocytes in humans. Clin Pharmacol Ther (1997) 0.92
Accurate characterization of ofloxacin susceptibility with Enterobacteriaceae using a modified GNS F6 card and the bioMerieux Vitek System. Diagn Microbiol Infect Dis (1996) 0.92
The MEF2C-Related and 5q14.3q15 Microdeletion Syndrome. Mol Syndromol (2012) 0.92
Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome: clinical and neuropathological observations in a 33-year-old man. Am J Med Genet (1998) 0.91
Lethal cutis laxa with contractural arachnodactyly, overgrowth and soft tissue bleeding due to a novel homozygous fibulin-4 gene mutation. Clin Genet (2009) 0.91
Monosomy 1p36--a recently delineated, clinically recognizable syndrome. Clin Dysmorphol (2002) 0.90
[Procedures according to data protection laws for coupling primary and secondary data in a cohort study: the lidA study]. Gesundheitswesen (2012) 0.90
Growth of heterokaryotic monozygotic twins discordant for Ullrich-Turner syndrome during the first years of life. Am J Med Genet A (2004) 0.90
Circulating immune complexes in patients with Candida albicans infections. Clin Exp Immunol (1983) 0.90
Clinical relevance of monosomy 22q11.2 in children with pulmonary atresia and ventricular septal defect. Eur J Pediatr (1999) 0.89
Disturbed Wnt Signalling due to a Mutation in CCDC88C Causes an Autosomal Recessive Non-Syndromic Hydrocephalus with Medial Diverticulum. Mol Syndromol (2010) 0.88
Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. Antimicrob Agents Chemother (2000) 0.88
J774A.1 macrophage cell line produces PDGF-like and non-PDGF-like growth factors for bone cells. J Bone Miner Res (1987) 0.88
Monosomy 22q11 in patients with pulmonary atresia, ventricular septal defect, and major aortopulmonary collateral arteries. Heart (1998) 0.88
Establishing goals and priorities in a surgery department. Med Teach (1992) 0.87
Comparison of results generated by serotyping, pulsed-field restriction analysis, ribotyping, and repetitive-sequence PCR used to characterize penicillin-resistant pneumococci from the United States. J Clin Microbiol (2001) 0.87
Mosaicism for the Charcot-Marie-Tooth disease type 1A duplication suggests somatic reversion. Hum Genet (1996) 0.87
Hirschsprung disease, mental retardation, characteristic facial features, and mutation in the gene ZFHX1B (SIP1): confirmation of the Mowat-Wilson syndrome. Am J Med Genet A (2003) 0.87
Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. Psychiatr Serv (1998) 0.87
The cost-effectiveness of clozapine: a survey of the literature. Clin Drug Investig (1998) 0.86
Somatic mosaicism in a mother of two children with Pitt-Hopkins syndrome. Clin Genet (2012) 0.86
Pneumococci can persistently colonize adult patients with chronic respiratory disease. J Clin Microbiol (2012) 0.86
Emphysematous cystitis due to Clostridium perfringens. JAMA (1981) 0.86
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infect Dis (2015) 0.86
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infect Dis (2014) 0.85
Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis. Clin Ther (1999) 0.85